期刊文献+

疏血通注射液治疗缺血性脑卒中的疗效观察 被引量:8

Efficacy Observation of Shuxuetong Injection in the Treatment of Ischemic Stroke
原文传递
导出
摘要 目的:观察疏血通注射液治疗缺血性脑卒中的疗效。方法:将182例缺血性脑卒中患者随机分为两组,治疗组94例,对照组88例。两组患者同时给予基础药物治疗,治疗组患者加用疏血通注射液6ml,qd,静脉滴注。两组患者疗程均为21d。所有患者分别于治疗前,治疗第7、14、21天进行神经功能缺损评分和日常生活活动能力检查、运动功能评定和脑血流图检测等。结果:治疗后两组患者的神经功能缺损情况、日常生活能力和运动功能均有所好转,脑血流量显著增加,与治疗前比较差异有统计学意义(P<0.05),且治疗组显著优于对照组(P<0.05)。结论:疏血通注射液能改善缺血性脑卒中患者神经功能缺损,提高患者的运动功能及日常生活能力。 OBJECTIVE: To observe the clinical efficacy of Shuxuetong injection in the treatment of ischemic stroke. METH- ODS: 182 patients with ischemic stroke were randomly divided into 2 groups, i.e. treatment group (94 cases) and control group (88 cases). On the basis of regular treatment, treatment group was treated with Shuxuetong injection 6 ml, i.v., qd. They were treated for 21 d. The neurological deficit score (NIHSS), activity of daily living (ADL), motor function evaluation and rheoen- cephalogram were measured at baseline and 1, 2 and 3 weeks after treatment. RESULTS: After treatment, NIHHS, ADL, motor function and cerebral blood flow of both groups were improved, there was statistical significance and the index of treatment group were better than that of control group (P〈0.05). CONCLUSIONS: Shuxuetong injection can improve neurologic deficits and en- hance motor function and activities of daily living of the patients with ischemic stroke.
出处 《中国药房》 CAS CSCD 2013年第24期2248-2250,共3页 China Pharmacy
关键词 疏血通注射液 缺血性脑卒中 疗效 神经功能缺损评分 日常生活活动能力检查 运动功能评定 Shuxuetong injection Ischemic stroke Efficacy NIHSS ADL Motor function evaluation
  • 相关文献

参考文献11

二级参考文献44

共引文献3439

同被引文献212

引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部